 | A major contributor to this article appears to have a close connection with its subject. (October 2018) |
| Formation | 2002 |
|---|---|
| Type | not-for-profit |
| Headquarters | Saratoga, California |
President, CEO and Founder | Scott Johnson |
| Website | http://www.myelinrepair.org |
The Myelin Repair Foundation (MRF) is a 501(c)(3) not-for-profit organization based in Saratoga, California. The organization applies a collaborative business model to the process of medical research with the aim of accelerating the identification and development of new patient treatments. MRF's goal is to license its first drug target for commercial drug development by July 1, 2009, five years after the organization began funding research.[1]
The MRF was created by entrepreneur Scott Johnson in 2002, and began funding research in 2004.[2]
On June 22, 2015, the Foundation announced that due to a lack of financing, it would begin the process of winding down.[3] However, additional donors stepped in to provide funding for the Foundation to continue its work with a smaller staff.[4]
- ^ Myelin Repair Foundation, "Vision and Mission." Archived 2008-10-29 at the Wayback Machine
- ^ "In middle of MS battle, pioneering foundation closing its doors". San Francisco Business Times. 2015-06-22.
- ^ "Myelin Repair Foundation to Cease Operations". Genetic Engineering & Biotechnology News. 2015-06-23.
- ^ Leuty, Ron. "On death bed, MS foundation revived (sort of) by donors". San Francisco Business Times. The Business Journals. Retrieved 27 August 2021.